DMCHY yields 6.98% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, DMCHY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DMCHY + PFE for your $10,000?
DMCI Holdings, Inc., through its subsidiaries, engages in the general construction, coal and nickel mining, power generation, real estate development, water concession, and manufacturing businesses in the Philippines and internationally. It operates through seven segments: Construction and Others, Coal Mining, Nickel Mining, Real Estate, On-Grid Power, Off-Grid Power, and Water. It constructs various projects comprising commercial and residential buildings; bridges, power plants, industrial plants; and chapels, hotels, irrigation dams, power transmission lines, and theaters. The company is also involved in the production and trading of concrete products; and handling steel fabrication, and electrical and foundation works. In addition, it engages in the development of mid-income residential properties under the DMCI Homes brand; generation of power through coal-fired and satellite power plants; exploration, mining, development, and sale of coal resources on Semirara Island in Caluya, Antique; mining, extracting, and selling of nickel, chromite, and iron laterite from Berong, Moorsom, and Ulugan mines in Palawan, as well as from Acoje mines in Zambales; and provision of water and sewerage service. The company was incorporated in 1995 and is based in Makati City, the Philippines.
Full DMCHY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.